Articles liés à Histological Typing of Lung and Pleural Tumours

Histological Typing of Lung and Pleural Tumours - Couverture souple

Travis, William D., M.D.; Colby, Thomas V.; Corrin, B.; Shimosato, Y.; Brambilla, E.

 
9783540652199: Histological Typing of Lung and Pleural Tumours
Couverture souple
ISBN 10 : 3540652191 ISBN 13 : 9783540652199
Editeur : Springer, 1999

Synopsis

Lung cancer is currently the most frequently diagnosed major cancer in the world and the most common cause of cancer mortality world­ wide. This is largely due to the carcinogenic effects of cigarette smoke. Over the coming decades, changes in smoking habits will greatly influ­ ence lung cancer incidence and mortality throughout the world. These changes may also impact upon the histological types of lung cancer. Tumour classification is important for consistency in patient treat­ ment, and because it provides a basis for epidemiologic and biologi­ cal studies. The previous WHO classification was published in 1981 and since then considerable progress has been made in our understanding of cer­ tain lung tumours 1. The concept of neuroendocrine tumours of the lung has been refined with recognition of large cell neuroendocrine carci­ noma and modification of criteria for atypical carcinoid. Atypical ade­ nomatous hyperplasia is now recognized as a potential precursor to adenocarcinoma. Studies have documented the histological hetero­ geneity of lung carcinomas, particularly among adenocarcinomas and poorly differentiated carcinomas. Molecular studies have also shown that hamartomas and sclerosing hemangiomas are true neoplasms rather than tumour-like lesions. This classification is based on histological characteristics of tumours seen in surgical or needle biopsy and autopsy material. Though a large percentage of lung carcinomas are now diagnosed on cytology specimens, the classification does not address cytology.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

À propos de la quatrième de couverture

Lung cancer is currently the most frequently diagnosed major cancer in the world and the most common cause of cancer mortality world­ wide. This is largely due to the carcinogenic effects of cigarette smoke. Over the coming decades, changes in smoking habits will greatly influ­ ence lung cancer incidence and mortality throughout the world. These changes may also impact upon the histological types of lung cancer. Tumour classification is important for consistency in patient treat­ ment, and because it provides a basis for epidemiologic and biologi­ cal studies. The previous WHO classification was published in 1981 and since then considerable progress has been made in our understanding of cer­ tain lung tumours 1. The concept of neuroendocrine tumours of the lung has been refined with recognition of large cell neuroendocrine carci­ noma and modification of criteria for atypical carcinoid. Atypical ade­ nomatous hyperplasia is now recognized as a potential precursor to adenocarcinoma. Studies have documented the histological hetero­ geneity of lung carcinomas, particularly among adenocarcinomas and poorly differentiated carcinomas. Molecular studies have also shown that hamartomas and sclerosing hemangiomas are true neoplasms rather than tumour-like lesions. This classification is based on histological characteristics of tumours seen in surgical or needle biopsy and autopsy material. Though a large percentage of lung carcinomas are now diagnosed on cytology specimens, the classification does not address cytology.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
Springer
Date d'édition
1999
Langue
anglais
ISBN 10 
3540652191
ISBN 13 
9783540652199
Reliure
Broché
Numéro d'édition
3
Nombre de pages
156
Coordonnées du fabricant
ProductSafety@springernature.com
ProductSafety@springernature.com

Europaplatz 3
Heidelberg
69115
Allemagne